About 14 results found for searched term "EF5" (0.068 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5116 | Formoterol Hemifumarate | Adrenergic Receptor |
| Eformoterol, CGP 25827A, NSC 299587, YM 08316 | ||
| Formoterol Hemifumarate is a potent, selective and long-acting β2-adrenoceptor agonist used in the management of asthma and chronic obstructive pulmonary disease. | ||
| M5490 | Cefmenoxime HCl | Antibiotic |
| Cefmenoxime hemihydrochloride, SCE-1365 hemihydrochloride | ||
| Cefmenoxime, a potent inhibitor of Enterobacteriaceae, is a cephalosporin antibiotic that is administered intravenously or intramuscularly. | ||
| M5495 | Cefotaxime sodium | Antibiotic |
| Cefotaxim sodium salt; HR-756 sodium | ||
| Cefotaxime sodium salt is a third-generation cephalosporin antibiotic; broad-spectrum antibiotic with activity against numerous Gram-positive and Gram-negative bacteria. | ||
| M6244 | Tomivosertib (eFT-508) | MNK |
| eFT508; Tomivosertib | ||
| Tomivosertib (eFT-508) is a potent and selective MNK1/2 inhibitor with IC50s of 2.4 nM and 1 nM, respectively. It potentially results in decreased tumor cell proliferation and tumor growth. | ||
| M8752 | EF5 | Others |
| EF5 is a 2-nitroimidazole-based hypoxia marker corresponding to a pentafluorinated derivative of the hypoxic cell-radiation sensitizer etanidazole. | ||
| M10232 | Cefotaxime | Anti-infection |
| Cefotaxima acid; HR-756 | ||
| Cefotaxime is an inhibitor of penicillin binding protein. | ||
| M10432 | Difelikefalin (CR-845; FE-202845) TFA | Opioid Receptor |
| Disomotide; KORSUVA; MR13A9 TFA | ||
| Difelikefalin (CR-845; FE-202845) TFA is a synthetic peptide and the first-in-class, peripherally-restricted, selective agonist of the κ-opioid receptor (KOR) for studies related to pruritus. | ||
| M11283 | Inolitazone dihydrochloride | PPAR |
| Efatutazone dihydrochloride; CS-7017 dihydrochloride; RS5444 dihydrochloride | ||
| Inolitazone dihydrochloride (Efatutazone dihydrochloride) is a PPARγ agonist with high affinity, activity dependent on PPARγ, inhibiting growth, IC50 is 0.8 nM. | ||
| M19930 | Cefpiramide acid | Anti-infection |
| Cefpiramide acid; Cefpiramido; Cefpiramidum; WY-44635; SM-1652 | ||
| Cefpiramide (Cefpiramide acid, Cefpiramido, Cefpiramidum, WY-44635, SM-1652) is a pseudomonas-active cephalosporin with a broad spectrum of antibacterial activity. | ||
| M25048 | Feladilimab | Others |
| Anti-ICOS/CD278 Reference Antibody; GSK3359609 | ||
| Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has the potential for the research of cancer. | ||
| M29393 | Inolitazone | PPAR |
| Efatutazone; CS-7017; RS5444 | ||
| Inolitazone a novel high-affinity PPARγ agonist that is dependent upon PPARγ for its biological activity with IC50 of 0.8 nM for growth inhibition. | ||
| M53448 | CEF1, Influenza Matrix Protein M1 (58-66) | Anti-infection |
| CEF1, Influenza Matrix Protein M1 (58-66) is an epitope derived from the matrix protein of the influenza A virus. | ||
| M53536 | CEF19, Epstein-Barr Virus latent NA-3A (458-466) | Anti-infection |
| CEF19, Epstein-Barr Virus latent NA-3A (458-466) is a single peptide epitope, YPLHEQHGM, representing residues 458-466 of the type 1 Epstein-Barr Virus (EBV) nuclear antigen 3A protein (B95.8 strain). | ||
| M53537 | CEF27, Epstein-Barr Virus BRLF-1 lytic (148-156) | Anti-infection |
| CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156 corresponding to amino acids 148-156 of the BRLF1 protein. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
